Phase I Clinical Trial To Test Combination Of Two HIV Vaccine Candidates Starts In London

Thursday, November 27, 2008 - 09:22 in Health & Medicine

Researchers have initiated a Phase I clinical trial in London, UK to test a prime-boost combination of two HIV vaccine candidates. The news follows promising results for one of the two vaccine candidates to be tested, the MVA-based TBC-M4, which in a recent phase I trial generated modest immune responses in all volunteers who received the highest dose.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net